Page last updated: 2024-10-25

clonidine and Bone Loss, Osteoclastic

clonidine has been researched along with Bone Loss, Osteoclastic in 1 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Limonard, EJ1
Schoenmaker, T1
de Vries, TJ1
Tanck, MW1
Heijboer, AC1
Endert, E1
Fliers, E1
Everts, V1
Bisschop, PH1

Trials

1 trial available for clonidine and Bone Loss, Osteoclastic

ArticleYear
Clonidine increases bone resorption in humans.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Biomarkers; Bone Remodeling; Bone Resorption; Cell

2016